iBio Announces Second COVID-19 Vaccine Program

NEXT STORY
Myriad Genetics Announces Publication of a Prospective Clinical Study of the EndoPredict® Test in Women with Early-Stage Breast Cancer
PREV STORY
Impact of COVID-19 on the Infectious Disease Testing Industry, 2020-2025
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Neovacs to Present at Bio International Convention 2016

PARIS and BOSTON, May 30, 2016 (GLOBE NEWSWIRE) -- Neovacs (Alternext Paris:ALNEV) a leader ...

author_avatar
NASDAQ Market News

North Americaportable oxygen concentratorsmarket is expected to reach US$ 1,315.42 million by 2027 from US$ 682.73 million in 2019

author_avatar
NASDAQ Market News

Orion’s and Bayer’s darolutamide shows substantial efficacy and a favourable safety profile in the treatment of prostate cancer in the ARAMIS trial

Orion Corporation                                                                            Press ReleaseCommunications                                                                              14 February 2019 at 11.45 p.m. EET Orion's and ...

author_avatar
NASDAQ Market News